Category: New products
-
Multi-Variant Covid-19 Vaccine in the Works
A vaccine protecting against multiple Covid-19 viral variations is in development, with an early-stage clinical trial expected to begin soon.
-
Registry Tracking Long-Term Covid-19 Impacts
A study now underway is tracking long-term effects of Covid-19 infections using real-world data from electronic sources provided by patients.
-
Micro-Robot Designed to Aid Internal Laser Surgery
An engineering team demonstrated a small robotic device that fits on current surgical equipment to improve laser surgery inside the body.
-
US Govt to Buy 1.25M Regeneron Covid-19 Therapies
The U.S. Department of Health and Human Services is buying up to 1.25 million more doses of Regeneron’s Covid-19 antibody therapy, for $2.63 billion.
-
Moderna Developing Flu, HIV, Nipah Vaccines
Moderna Inc., developer of a currently authorized Covid-19 vaccine, is expanding its vaccine pipeline to cover three more common infectious viral diseases.
-
Infographic – Countries Making Covid-19 Vaccines
The U.S. and India are set to produce two-thirds of the world’s Covid-19 vaccine doses by the end of this year, presenting worldwide distribution challenges.
-
Digital Therapeutics Designed for Cancer/Covid-19 Stress
A digital health company is partnering with cancer advocacy organizations to provide electronic therapies to help patients deal with stresses from Covid-19.
-
Vaccine Shown Active Against New Covid-19 Variants
A current Covid-19 vaccine is shown in lab tests to produce antibodies that appear to protect against new mutations found in South Africa and the U.K.
-
Stem Cells Help Severe Covid-19 Cases Recover
Results of a clinical trial show stem cells from umbilical cord linings help patients with severe respiratory disease recover and survive from Covid-19 infections.
-
Synthetic Virus Company Forms, Raises $77M
A new biotechnology enterprise is underway that develops synthetic viruses attacking solid tumor cancers, based on research at the Salk Institute.